Before TAVR
Limited evidence to date
30 days and 12 months mortality similar in revascularized versus non-revascularized patients
Myocardial infarction and major stroke higher in individuals undergoing revascularization and/or presence of any stenosis >50 %, but not statistically different
At the time of TAVR
Limited evidence to date
30 days mortality similar to those undergoing percutaneous revascularization versus no revascularization
After TAVR
May be technically difficult due to value struts that may interfere with percutaneous intervention
Limited evidence to date
Observational data for percutaneous revascularization reveals no increased need for coronary artery bypass surgery with generally high survival
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7.PubMedCrossRef